- Report
- August 2022
- 115 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2024
- 250 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2024
- 250 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Drug Pipelines
- April 2021
- 78 Pages
Global
€20022EUR$22,000USD£17,165GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
- Report
- November 2022
- 335 Pages
Global
From €3249EUR$3,570USD£2,785GBP
Revatio is a brand name for sildenafil citrate, a medication used to treat pulmonary arterial hypertension (PAH) and improve exercise capacity in men and women. It is a type of cardiovascular drug, which is used to treat high blood pressure in the arteries of the lungs. Revatio works by relaxing the blood vessels in the lungs, allowing blood to flow more easily and reducing the workload on the heart. It is also used to treat erectile dysfunction in men.
Revatio is available in tablet form and is taken orally, usually once a day. It is important to take the medication as prescribed by your doctor. Common side effects of Revatio include headache, flushing, dizziness, and nausea.
The Revatio market is a subset of the larger cardiovascular drug market. It is a growing market, with more people being diagnosed with PAH and other cardiovascular conditions. As the population ages, the demand for cardiovascular drugs is expected to increase.
Companies in the Revatio market include Pfizer, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more